Status:
COMPLETED
Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia After Cesarean Section
Lead Sponsor:
Columbia University
Conditions:
Postoperative Pain
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
HYPOTHESIS: The response to a given dose of morphine given via a spinal anesthetic for cesarean section will be affected by the genetics of the woman's mu-opioid receptor Most women undergoing electi...
Eligibility Criteria
Inclusion
- healthy women undergoing elective cesarean
Exclusion
- cardiovascular disease
- analgesic medications
- complications of pregnancy
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
169 Patients enrolled
Trial Details
Trial ID
NCT01465191
Start Date
November 1 2011
End Date
May 1 2014
Last Update
December 10 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
George Washington University Medical Center
Washington D.C., District of Columbia, United States, 20037
2
Columbia University Medical Center
New York, New York, United States, 10032